| Segment / region | Type | Fiscal year | Currency | Revenue (millions) | Share of revenue |
|---|---|---|---|---|---|
| UNITED STATES | Region | 2024 | USD | 241,563.0 | 100.0% |
| UNITED STATES | Region | 2023 | USD | 189,840.0 | 97.8% |
| All Other Countries | Region | 2023 | USD | 4,259.0 | 2.2% |
| UNITED STATES | Region | 2022 | USD | 174,539.0 | 97.3% |
| All Other Countries | Region | 2022 | USD | 4,822.0 | 2.7% |
| UNITED STATES | Region | 2021 | USD | 166,626.0 | 96.6% |
| All Other Countries | Region | 2021 | USD | 5,903.0 | 3.4% |
| UNITED STATES | Region | 2020 | USD | 154,042.0 | 96.8% |
| All Other Countries | Region | 2020 | USD | 2,992.0 | 1.9% |
| KOREA, REPUBLIC OF | Region | 2020 | USD | 2,123.0 | 1.3% |
| Evernorth | Product | 2025 | USD | 234,953.0 | 83.2% |
| Cigna Healthcare | Product | 2025 | USD | 47,412.0 | 16.8% |
| Evernorth | Product | 2024 | USD | 198,177.0 | 80.7% |
| Cigna Healthcare | Product | 2024 | USD | 47,528.0 | 19.3% |
| Evernorth Health Services | Product | 2023 | USD | 147,829.0 | 75.7% |
| Cigna Healthcare | Product | 2023 | USD | 46,816.0 | 24.0% |
| Other | Product | 2023 | USD | 596.0 | 0.3% |
| Corporate and Eliminations | Product | 2023 | USD | 24.0 | 0.0% |
| Evernorth Health Services | Product | 2022 | USD | 135,872.0 | 75.3% |
| Cigna Healthcare | Product | 2022 | USD | 42,375.0 | 23.5% |
| Other | Product | 2022 | USD | 2,262.0 | 1.3% |
| Corporate and Eliminations | Product | 2022 | USD | 7.0 | 0.0% |
| Evernorth Health Services | Product | 2021 | USD | 127,709.0 | 73.4% |
| Cigna Healthcare | Product | 2021 | USD | 42,381.0 | 24.4% |
| Other | Product | 2021 | USD | 3,989.0 | 2.3% |
| Corporate and Eliminations | Product | 2021 | USD | (1.0) | 0.0% |
| Evernorth Health Services | Product | 2020 | USD | 112,679.0 | 70.3% |
| Cigna Healthcare | Product | 2020 | USD | 36,474.0 | 22.7% |
| International Markets | Product | 2020 | USD | 6,007.0 | 3.7% |
| Other | Product | 2020 | USD | 5,241.0 | 3.3% |
Product and geographic breakdowns describe the same revenue from different perspectives and should not be added together.
